About
Next-Generation, Cancer Immunotherapy
Areas of Focus
Categories
Stem Cell & Cellular TherapySoutheastern U.S.
Clinical Trials (7)
View allTotal Trials
7
As Lead Sponsor
7
As Collaborator
0
Total Enrollment
740
By Phase
PHASE3: 1NA: 2PHASE2: 2PHASE1/PHASE2: 1PHASE1: 1
By Status
COMPLETED: 6SUSPENDED: 1
Clinical Trials Pipeline7 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT02546102Lead Sponsor
Phase 3 Randomized, Double-blind, Controlled Study of ICT-107 in Glioblastoma
PHASE3Suspended
234 participants
Started: Dec 31, 2024 · Completed: Dec 31, 2025
NCT04925440Lead Sponsor
The Effects of Bifidobacterium Longum 1714® in a Population With Low Mood
NACompleted
168 participants
Started: Sep 13, 2021 · Completed: Aug 19, 2022
NCT04922476Lead Sponsor
Effect of 35624® Alflorex® in Functional Gastrointestinal Disorders (FGIDs) in Children.
NACompleted
65 participants
Started: Aug 6, 2021 · Completed: Apr 4, 2023
NCT04167475Lead Sponsor
Effect of B. Longum 1714™ on Sleep Quality
PHASE2Completed
89 participants
Started: Jan 6, 2020 · Completed: Jun 23, 2020
NCT04422327Lead Sponsor
The Impact of a Combination of Bifidobacterium Longum 35624® and 1714™ Strains in Adults With Irritable Bowel Syndrome
PHASE1/PHASE2Completed
40 participants
Started: Sep 20, 2017 · Completed: Feb 12, 2018
Locations (1)
Headquarters
Nashville, TN, United States
Map
Loading map...